Cost utility of sequential adjuvant trastuzumab for HER2/Neu-positive breast cancer.

Journal Article

Full Text

Duke Authors

Cited Authors

  • Reed, SD; Schulman, KA

Published Date

  • July 2009

Published In

Volume / Issue

  • 12 / 5

Start / End Page

  • 637 - 640

PubMed ID

  • 19473336

Pubmed Central ID

  • 19473336

Electronic International Standard Serial Number (EISSN)

  • 1524-4733

Digital Object Identifier (DOI)

  • 10.1111/j.1524-4733.2009.00564.x

Language

  • eng

Conference Location

  • United States